134 related articles for article (PubMed ID: 31071499)
1. Generation of an induced pluripotent stem cell line (TRNDi008-A) from a Hunter syndrome patient carrying a hemizygous 208insC mutation in the IDS gene.
Hong J; Xu M; Li R; Cheng YS; Kouznetsova J; Beers J; Liu C; Zou J; Zheng W
Stem Cell Res; 2019 May; 37():101451. PubMed ID: 31071499
[TBL] [Abstract][Full Text] [Related]
2. An induced pluripotent stem cell line (TRNDi006-A) from a MPS IIIB patient carrying homozygous mutation of p.Glu153Lys in the NAGLU gene.
Huang W; Xu M; Li R; Baskfield A; Kouznetsova J; Beers J; Zou J; Liu C; Zheng W
Stem Cell Res; 2019 May; 37():101427. PubMed ID: 30933722
[TBL] [Abstract][Full Text] [Related]
3. A human induced pluripotent stem cell line (TRNDi007-B) from an infantile onset Pompe patient carrying p.R854X mutation in the GAA gene.
Cheng YS; Li R; Baskfield A; Beers J; Zou J; Liu C; Zheng W
Stem Cell Res; 2019 May; 37():101435. PubMed ID: 31026687
[TBL] [Abstract][Full Text] [Related]
4. Generation of an induced pluripotent stem cell line (TRNDi004-I) from a Niemann-Pick disease type B patient carrying a heterozygous mutation of p.L43_A44delLA in the SMPD1 gene.
Baskfield A; Li R; Beers J; Zou J; Liu C; Zheng W
Stem Cell Res; 2019 May; 37():101436. PubMed ID: 31009819
[TBL] [Abstract][Full Text] [Related]
5. Generation of Mucopolysaccharidosis type II (MPS II) human induced pluripotent stem cell (iPSC) line from a 3-year-old male with pathogenic IDS mutation.
Varga E; Nemes C; Bock I; Varga N; Fehér A; Kobolák J; Dinnyés A
Stem Cell Res; 2016 Nov; 17(3):479-481. PubMed ID: 27789398
[TBL] [Abstract][Full Text] [Related]
6. Generation of Mucopolysaccharidosis type II (MPS II) human induced pluripotent stem cell (iPSC) line from a 7-year-old male with pathogenic IDS mutation.
Varga E; Nemes C; Bock I; Varga N; Fehér A; Kobolák J; Dinnyés A
Stem Cell Res; 2016 Nov; 17(3):463-465. PubMed ID: 27789394
[TBL] [Abstract][Full Text] [Related]
7. Generation of Mucopolysaccharidosis type II (MPS II) human induced pluripotent stem cell (iPSC) line from a 1-year-old male with pathogenic IDS mutation.
Varga E; Nemes C; Bock I; Varga N; Fehér A; Dinnyés A; Kobolák J
Stem Cell Res; 2016 Nov; 17(3):482-484. PubMed ID: 27789399
[TBL] [Abstract][Full Text] [Related]
8. Generation of an induced pluripotent stem cells line, CSSi014-A 9407, carrying the variant c.479C>T in the human iduronate 2-sulfatase (hIDS) gene.
Casamassa A; Zanetti A; Ferrari D; Lombardi I; Galluzzi G; D'Avanzo F; Cipressa G; Bertozzi A; Torrente I; Vescovi AL; Tomanin R; Rosati J
Stem Cell Res; 2022 Aug; 63():102846. PubMed ID: 35759972
[TBL] [Abstract][Full Text] [Related]
9. iPS-derived neural stem cells for disease modeling and evaluation of therapeutics for mucopolysaccharidosis type II.
Hong J; Cheng YS; Yang S; Swaroop M; Xu M; Beers J; Zou J; Huang W; Marugan JJ; Cai X; Zheng W
Exp Cell Res; 2022 Mar; 412(1):113007. PubMed ID: 34990619
[TBL] [Abstract][Full Text] [Related]
10. Molecular diagnosis of 65 families with mucopolysaccharidosis type II (Hunter syndrome) characterized by 16 novel mutations in the IDS gene: Genetic, pathological, and structural studies on iduronate-2-sulfatase.
Kosuga M; Mashima R; Hirakiyama A; Fuji N; Kumagai T; Seo JH; Nikaido M; Saito S; Ohno K; Sakuraba H; Okuyama T
Mol Genet Metab; 2016 Jul; 118(3):190-197. PubMed ID: 27246110
[TBL] [Abstract][Full Text] [Related]
11. Generation of human induced pluripotent stem cell (iPSC) line from an unaffected female carrier of Mucopolysaccharidosis type II (MPS II) disorder.
Varga E; Nemes C; Kovács E; Bock I; Varga N; Fehér A; Dinnyés A; Kobolák J
Stem Cell Res; 2016 Nov; 17(3):514-516. PubMed ID: 27789401
[TBL] [Abstract][Full Text] [Related]
12. Neural cells generated from human induced pluripotent stem cells as a model of CNS involvement in mucopolysaccharidosis type II.
Rybová J; Ledvinová J; Sikora J; Kuchař L; Dobrovolný R
J Inherit Metab Dis; 2018 Mar; 41(2):221-229. PubMed ID: 29168031
[TBL] [Abstract][Full Text] [Related]
13. GENYOi004-A: An induced pluripotent stem cells (iPSCs) line generated from a patient with autism-related ADNP syndrome carrying a pTyr719* mutation.
Montes R; Mollinedo P; Perales S; Gonzalez-Lamuño D; Ramos-Mejía V; Fernandez-Luna JL; Real PJ
Stem Cell Res; 2019 May; 37():101446. PubMed ID: 31035039
[TBL] [Abstract][Full Text] [Related]
14. Case report: a rare case of Hunter syndrome (type II mucopolysaccharidosis) in a girl.
Semyachkina AN; Voskoboeva EY; Zakharova EY; Nikolaeva EA; Kanivets IV; Kolotii AD; Baydakova GV; Kharabadze MN; Kuramagomedova RG; Melnikova NV
BMC Med Genet; 2019 May; 20(1):66. PubMed ID: 31046699
[TBL] [Abstract][Full Text] [Related]
15. Molecular analysis of the iduronate-2-sulfatase gene in Thai patients with Hunter syndrome.
Keeratichamroen S; Cairns JR; Wattanasirichaigoon D; Wasant P; Ngiwsara L; Suwannarat P; Pangkanon S; Kuptanon J; Tanpaiboon P; Rujirawat T; Liammongkolkul S; Svasti J
J Inherit Metab Dis; 2008 Dec; 31 Suppl 2():S303-11. PubMed ID: 18500569
[TBL] [Abstract][Full Text] [Related]
16. Reprogramming of a human induced pluripotent stem cell (iPSC) line (IBMSi012-A) from an early-onset Parkinson's disease patient harboring a homozygous p.D331Y mutation in the PLA2G6 gene.
Cheng YC; Lin HI; Syu SH; Lu HE; Huang CY; Lin CH; Hsieh PCH
Stem Cell Res; 2019 May; 37():101432. PubMed ID: 30978640
[TBL] [Abstract][Full Text] [Related]
17. Generation of induced pluripotent stem cells (IBMSi011-A) from a patient with Parkinson's disease carrying LRRK2 p.I1371V mutation.
Lin HI; Cheng YC; Ko HW; Wen CH; Lu HE; Huang CY; Hsieh PCH; Lin CH
Stem Cell Res; 2019 May; 37():101447. PubMed ID: 31029016
[TBL] [Abstract][Full Text] [Related]
18. The mutational spectrum of hunter syndrome reveals correlation between biochemical and clinical profiles in Tunisian patients.
Chkioua L; Grissa O; Leban N; Gribaa M; Boudabous H; Turkia HB; Ferchichi S; Tebib N; Laradi S
BMC Med Genet; 2020 May; 21(1):111. PubMed ID: 32448126
[TBL] [Abstract][Full Text] [Related]
19. Genetic analysis of 17 children with Hunter syndrome: identification and functional characterization of four novel mutations in the iduronate-2-sulfatase gene.
Chistiakov DA; Kuzenkova LM; Savost'anov KV; Gevorkyan AK; Pushkov AA; Nikitin AG; Vashakmadze ND; Zhurkova NV; Podkletnova TV; Namazova-Baranova LS; Baranov AA
J Genet Genomics; 2014 Apr; 41(4):197-203. PubMed ID: 24780617
[TBL] [Abstract][Full Text] [Related]
20. Enigmatic in vivo iduronate-2-sulfatase (IDS) mutant transcript correction to wild-type in Hunter syndrome.
Lualdi S; Tappino B; Di Duca M; Dardis A; Anderson CJ; Biassoni R; Thompson PW; Corsolini F; Di Rocco M; Bembi B; Regis S; Cooper DN; Filocamo M
Hum Mutat; 2010 Apr; 31(4):E1261-85. PubMed ID: 20104590
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
